Other studies on prostate carcinoma and NSCLC, have shown that higher levels of TRIM16 lead to the inhibition of the EMT process and tumor cells invasion (Huo et al., 2015; Qi et al., 2016). The gene discussed is TRIM16; the disease is prostate carcinoma.